Rehabilitation program using robotic walking and electrical stimulation for children with cerebral palsy
The Effect of a Comprehensive Rehabilitation Program Using Robotic Walking and Functional Electrical Stimulation Technologies on Balance and Walking in Children With Cerebral Palsy
This study is testing if a new rehabilitation program that uses robotic walking and electrical stimulation can help improve balance and walking in children with cerebral palsy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 2 Years to 18 Years |
| Sex | All |
| Sponsor | Ankara City Hospital Bilkent Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06403891 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of a comprehensive rehabilitation program that incorporates robotic walking and functional electrical stimulation technologies on balance and gait in children diagnosed with cerebral palsy. It is designed as a prospective observational study involving 30 patients divided into two groups. Both groups will undergo a 6-week conventional rehabilitation program tailored to their clinical needs, while the case group will additionally receive advanced rehabilitation using high-tech devices. The aim is to assess improvements in mobility and balance through these innovative interventions.
Who should consider this trial
Good fit: Ideal candidates are children aged 2-18 with a diagnosis of cerebral palsy who can walk independently with or without assistance.
Not a fit: Patients with contractures in the lower extremities or those who have received botulinum toxin treatment recently may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance mobility and quality of life for children with cerebral palsy.
How similar studies have performed: While similar approaches using robotic and electrical stimulation technologies have shown promise, this specific combination in a comprehensive program is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being between the ages of 2-18 * Being diagnosed with cerebral palsy * Walking independently with or without an assistive walking device * Having a GMFCS score between 1-3 * Lack of seizure history * Showing consent to participate in the study (signing the informed consent by the legal guardian of the patient) Exclusion Criteria: * Presence of contracture in lower extremities * Being administered botulinum toxin within the last one month before treatment or during the 6-week treatment period * Being unable to cooperate with clinical assessments
Where this trial is running
Ankara
- Ankara Bilkent City Hospital — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Berat M Alkan, Professor
- Email: beratalkan73@gmail.com
- Phone: +90 312 552 60 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.